# OnCo record alexander-drilon (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/alexander-drilon/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "alexander-drilon" ;
  schema:name "Alexander Drilon"@en ;
  schema:description "Led the trials of larotrectinib, entrectinib, repotrectinib and selpercatinib that turned rare gene fusions into treatable targets."@en ;
  schema:url <https://onco.cc/people/alexander-drilon/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.mskcc.org/cancer-care/doctors/alexander-drilon>, <https://pubmed.ncbi.nlm.nih.gov/?term=Drilon%20A%5BAuthor%5D> ;
  schema:jobTitle "Chief, Early Drug Development Service" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/thyroid/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/ntrk/>, <https://onco.cc/targets/ros1/>, <https://onco.cc/targets/ret/> ;
  onco:drugs <https://onco.cc/drugs/repotrectinib/>, <https://onco.cc/drugs/selpercatinib/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .